SCHEMBL23033142

SCHEMBL23033142

NC(=O)[C@@H]1CC1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2520806 1.00
SCHEMBL21242582 1.00
SCHEMBL12162660 0.78
SCHEMBL29634723 0.76
SCHEMBL25053929 0.76
SCHEMBL9684760 0.76 KMT2A (0.34)
SCHEMBL28137306 0.75 CHRNB2 (0.41)
SCHEMBL28152363 0.75 CHRNB2 (0.41)
SCHEMBL28151260 0.75 CHRNB2 (0.41)
SCHEMBL29567784 0.74 KMT2A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4038063-B1 HETEROCYCLIC COMPOUNDS FOR INHIBITING TYK2 ACTIVITIES BEIJING INNOCARE PHARMA TECH CO LTD (CN) 2024-04-24 EP disclosed
US-11578058-B2 Heterocyclic compounds for inhibiting TYK2 activities Beijing Innocare Pharma Tech Co. (CN) 2023-02-14 US disclosed
US-11578058-B2 Heterocyclic compounds for inhibiting TYK2 activities Beijing Innocare Pharma Tech Co. (CN) 2023-02-14 US disclosed
CN-114650990-B Heterocyclic compounds for inhibiting TYK2 activity 北京诺诚健华医药科技有限公司 2023-02-03 CN disclosed
US-20220259184-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITING TYK2 ACTIVITIES BEIJING INNOCARE PHARMA TECH CO. LTD. (CN) 2022-08-18 US disclosed
EP-4038063-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITING TYK2 ACTIVITIES Beijing InnoCare Pharma Tech Co., Ltd. (CN) 2022-08-10 EP disclosed
CN-114650990-A Heterocyclic compounds inhibiting TYK2 activity 北京诺诚健华医药科技有限公司 2022-06-21 CN disclosed
WO-2021254133-A1 SMALL MOLECULE COMPOUND 嘉兴特科罗生物科技有限公司 2021-12-23 WO disclosed
WO-2021180072-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITING TYK2 ACTIVITIES BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2021-09-16 WO disclosed
WO-2021032209-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF 四川海思科制药有限公司 2021-02-25 WO disclosed